Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Finished Goods (2018 - 2025)

Jaguar Health (JAGX) has disclosed Finished Goods for 8 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Finished Goods rose 21.51% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, up 21.51% year-over-year, with the annual reading at $1.3 million for FY2025, 21.51% up from the prior year.
  • Finished Goods for Q4 2025 was $1.3 million at Jaguar Health, up from $1.2 million in the prior quarter.
  • The five-year high for Finished Goods was $1.7 million in Q2 2022, with the low at $553000.0 in Q1 2021.
  • Average Finished Goods over 5 years is $1.0 million, with a median of $969500.0 recorded in 2021.
  • The sharpest move saw Finished Goods soared 105.06% in 2021, then crashed 53.55% in 2023.
  • Over 5 years, Finished Goods stood at $892000.0 in 2021, then surged by 48.43% to $1.3 million in 2022, then plummeted by 53.55% to $615000.0 in 2023, then surged by 76.91% to $1.1 million in 2024, then rose by 21.51% to $1.3 million in 2025.
  • According to Business Quant data, Finished Goods over the past three periods came in at $1.3 million, $1.2 million, and $1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.